Third Affiliated Hospital of Harbin Medical University

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Integration of Insomnia-Related Network Perturbation Reveals Distinct Molecular Subtypes and Therapeutic Vulnerabilities in Breast Cancer

<title>Abstract</title> Core circadian regulatory genes orchestrate vital physiological processes through temporal coordination of organ function, cellular metabolism, and mitot...

Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer

Both HER2 and ESR1 are determinant of KN026 efficacy in advanced HER2-positive breast cancer, implying the potential of KN026 combined with endocrine therapy in HER2- and ER-pos...

Development and validation of a plasma-urine metabolism diagnostic model for renal cell carcinoma using machine learning

A socioecological model of multilevel determinants for proactive health behaviors among Chinese adults with chronic diseases

Governments should transform medical insurance from a passive payer into an active health investor. By incorporating behavioral economics principles, such a reform reallocates p...